Updated Jul 16, 2026
Watts Ryan J. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $8.54M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-03 | DNLI | Denali Therapeutics Inc. | G — Bona-fide gift | 50.0K | $0.00 | |
| 2025-07-09 | DNLI | Denali Therapeutics Inc. | S — Open-market sale | 495.3K | $15.00 | $7.43M |
| 2025-07-09 | DNLI | Denali Therapeutics Inc. | M — Option exercise | 40.0K | $5.28 | $211K |
| 2025-07-09 | DNLI | Denali Therapeutics Inc. | M — Option exercise | 455.3K | $0.68 | $310K |
| 2024-10-22 | DNLI | Denali Therapeutics Inc. | S — Open-market sale [10b5-1] | 40.0K | $27.69 | $1.11M |
| 2024-10-22 | DNLI | Denali Therapeutics Inc. | M — Option exercise [10b5-1] | 40.0K | $0.68 | $27K |
Watts Ryan J. is a corporate insider — currently tracked as President and CEO, Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($8.54M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Watts Ryan J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.